Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI‐DNA complexes
- 24 March 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (8) , 884-894
Abstract
Background: p53 is frequently mutated in many cancers including human head and neck squamous cell carcinoma and pancreatic cancer. In tumor models, wild‐type (wt) p53 gene transfer induces apoptosis and tumor regression in vivo, justifying the extensive clinical investigation of p53 gene therapy.Methods: p53 nonviral‐mediated gene transfer was achieved using glucosylated polyethylenimine (PEI) in conjunction with photochemical internalisation (PCI). Experimental conditions were optimised using the green fluorescent protein (GFP) as a reporter. p53 gene transfer was then evaluated using semi‐quantitative RT‐PCR in p53‐deleted PANC3 and p53‐mutated FaDu cell lines. Following gene transfer, induction of apoptosis was investigated using phosphatidylserine externalisation and nuclear fragmentation assays. Induction of long‐term cell death was analysed using colony‐forming assays.Results: PCI was found to enhance GFP gene transfer after 48 h in both cell lines. Whether using glucosylated‐PEI alone or associated with PCI, p53 gene transfer was achieved with subsequent recovery of p53 mRNA expression in PANC3 cells and a significant 4‐fold increase in p53 mRNA expression in FaDu cells. PCI was found to further enhance p53 mRNA expression by 2.3‐fold in PANC3 cells. Spontaneous induction of apoptosis following wt‐p53 gene transfer was achieved in both cell lines. PCI was found to enhance apoptosis up to levels similar to those achieved with chemotherapy. As a consequence, long‐term cell death was significantly enhanced after wt‐p53 gene transfer when PCI was used in both cell lines, yielding up to 60% cell death.Conclusions: PCI increases glucosylated‐PEI‐mediated p53 gene transfer, apoptosis as well as cell death in mutant p53 human cancer cells. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene TherapyJournal of Clinical Oncology, 2003
- Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancerCancer Gene Therapy, 2003
- In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vectorCancer Gene Therapy, 2002
- A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerCancer Gene Therapy, 2002
- Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500Cancer Gene Therapy, 2002
- Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cellsCancer Gene Therapy, 2001
- Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivativesCancer Gene Therapy, 2001
- Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivoGene Therapy, 2001
- A Passive‐Marker‐Based Optical System for Computer‐Aided Surgery in Otorhinolaryngology: Development and First Clinical ExperiencesThe Laryngoscope, 1999
- ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivoGene Therapy, 1997